Institute of Cancer Policy, King's College London, London, United Kingdom; Department of Clinical Oncology, Guy's & St Thomas' NHS Trust, London, United Kingdom.
Institute of Cancer Policy, King's College London, London, United Kingdom; Evalumetrics Ltd, London, United Kingdom.
Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):767-778. doi: 10.1016/j.ijrobp.2018.03.009. Epub 2018 Mar 20.
Radiation therapy is a core modality of cancer treatment; however, concerns have been expressed regarding its underutilization and its lack of prioritization as a research domain relative to other cancer treatment modalities, despite its rapid technical evolution. It is therefore important to understand, from a public policy perspective, the evolution of global radiation therapy research, to identify strengths, weaknesses, and opportunities. This study used a bibliometric approach to undertake a quantitative analysis of global radiation therapy research published between 2001 and 2015 and available in the Web of Science (Wos) database, with particular focus on the 25 leading research-active countries. A total of 62,550 radiation therapy research articles from 127 countries, published in 2531 international journals, were analyzed. The United States was responsible for 32.3% of these outputs, followed by Japan (8.0%) and Germany (7.7%). Nearly half of all publications related to preparation and delivery of radiation therapy, combined-modality regimens, and dose fractionation studies. Health services research, palliative care, and quality of life studies represented only 2%, 5%, and 4% of all research outputs, respectively. Countries varied significantly in their commitment to different research domains, and trial-related publications represented only 5.1% of total output. Research impact was analyzed according to 3 different citation scores, with research outputs from Denmark, The Netherlands, and the United States consistently the highest ranked. Globally, radiation therapy publication outputs continue to increase but lag behind other spheres of cancer management. The types of radiation therapy research undertaken appear to be regionally patterned, and there is a clear disconcordance between the volume of research output from individual countries and its citation impact. Greater support for radiation therapy research in low- and middle-income countries is required, including international collaboration. The study findings are expected to provide the requisite knowledge to guide future radiation therapy research programs.
放射治疗是癌症治疗的核心手段;然而,尽管放射治疗技术发展迅速,人们对其利用率低以及相对于其他癌症治疗手段缺乏优先地位表示担忧。因此,从公共政策的角度了解全球放射治疗研究的演变,确定其优势、劣势和机会非常重要。本研究采用文献计量学方法,对 2001 年至 2015 年间在 Web of Science (Wos) 数据库中发表的全球放射治疗研究进行了定量分析,特别关注 25 个主要的研究活跃国家。共分析了来自 127 个国家的 62550 篇放射治疗研究论文,发表在 2531 种国际期刊上。这些产出中,美国占 32.3%,其次是日本(8.0%)和德国(7.7%)。近一半的出版物与放射治疗的准备和交付、联合治疗方案以及剂量分割研究有关。卫生服务研究、姑息治疗和生活质量研究分别仅占所有研究产出的 2%、5%和 4%。各国在不同研究领域的投入差异很大,与试验相关的出版物仅占总产出的 5.1%。根据 3 种不同的引用分数分析了研究的影响,丹麦、荷兰和美国的研究产出排名始终最高。全球范围内,放射治疗的出版物数量持续增加,但仍落后于癌症管理的其他领域。所进行的放射治疗研究类型似乎具有区域性模式,个别国家的研究产出数量与其引用影响力之间存在明显差异。需要为中低收入国家提供更多的放射治疗研究支持,包括国际合作。研究结果预计将提供必要的知识,以指导未来的放射治疗研究计划。